Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Bergmann

Showing results (91-100 of 175) with videos related to

Pageof 18
Sort By:
Surgery|July 10, 2012
Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancerOliver Strobel, Viktoria Berens, Ulf Hinz, et al.
Human Pathology|September 16, 2008
Fundamental differences in the neural invasion behavior of pancreatic endocrine tumors: relevance for local recurrence rates?Frank Bergmann, Güralp O Ceyhan, Ralf J Rieker, et al.
Annals of Surgery|December 6, 2016
Pancreatic Cancer Surgery: The New R-status CountsOliver Strobel, Thomas Hank, Ulf Hinz, et al.
Pancreas|September 25, 2012
Heme oxygenase 1-generated carbon monoxide and biliverdin attenuate the course of experimental necrotizing pancreatitisPhilipp Nuhn, Tomas Mitkus, Güralp O Ceyhan, et al.
Surgery|July 10, 2012
Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreasStefan Fritz, Moritz Schirren, Miriam Klauss, et al.
Cancer Letters|May 20, 2008
Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancerMartin Loos, Nathalia A Giese, Jörg Kleeff, et al.
The American Journal of Gastroenterology|July 2, 2009
Pancreatic neuropathy results in "neural remodeling" and altered pancreatic innervation in chronic pancreatitis and pancreatic cancerGüralp Onur Ceyhan, Ihsan Ekin Demir, Ulrich Rauch, et al.
Annals of Surgical Oncology|June 12, 2014
Prognostic impact of CA 19-9 on outcome after neoadjuvant chemoradiation in patients with locally advanced pancreatic cancerStephanie E Combs, Daniel Habermehl, Kerstin A Kessel, et al.
Annals of Surgery|June 27, 2022
Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic CancerThomas Hank, Ulla Klaiber, Ulf Hinz, et al.
Oncotarget|October 6, 2017
<i>HYAL2</i> methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control studySarah Schott, Rongxi Yang, Sarah Stöcker, et al.
Pageof 18

Showing results (91-100 of 175) with videos related to

Sort By:
Pageof 18
Surgery|July 10, 2012
Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancerOliver Strobel, Viktoria Berens, Ulf Hinz, et al.
Human Pathology|September 16, 2008
Fundamental differences in the neural invasion behavior of pancreatic endocrine tumors: relevance for local recurrence rates?Frank Bergmann, Güralp O Ceyhan, Ralf J Rieker, et al.
Annals of Surgery|December 6, 2016
Pancreatic Cancer Surgery: The New R-status CountsOliver Strobel, Thomas Hank, Ulf Hinz, et al.
Pancreas|September 25, 2012
Heme oxygenase 1-generated carbon monoxide and biliverdin attenuate the course of experimental necrotizing pancreatitisPhilipp Nuhn, Tomas Mitkus, Güralp O Ceyhan, et al.
Surgery|July 10, 2012
Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreasStefan Fritz, Moritz Schirren, Miriam Klauss, et al.
Cancer Letters|May 20, 2008
Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancerMartin Loos, Nathalia A Giese, Jörg Kleeff, et al.
The American Journal of Gastroenterology|July 2, 2009
Pancreatic neuropathy results in "neural remodeling" and altered pancreatic innervation in chronic pancreatitis and pancreatic cancerGüralp Onur Ceyhan, Ihsan Ekin Demir, Ulrich Rauch, et al.
Annals of Surgical Oncology|June 12, 2014
Prognostic impact of CA 19-9 on outcome after neoadjuvant chemoradiation in patients with locally advanced pancreatic cancerStephanie E Combs, Daniel Habermehl, Kerstin A Kessel, et al.
Annals of Surgery|June 27, 2022
Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic CancerThomas Hank, Ulla Klaiber, Ulf Hinz, et al.
Oncotarget|October 6, 2017
<i>HYAL2</i> methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control studySarah Schott, Rongxi Yang, Sarah Stöcker, et al.
Pageof 18